CareDx, Inc. (CDNA) Financial Statements (2024 and earlier)

Company Profile

Business Address 8000 MARINA BLVD
BRISBANE, CA 94005
State of Incorp. DE
Fiscal Year End December 31
Industry (SIC) 8071 - Medical Laboratories (benchmarking)
More info Complete Financial Analysis Financial Benchmarking

Balance Sheet (Statement of Financial Position) ($ in thousands)

9/30/2023
Q3
6/30/2023
Q2
3/31/2023
Q1
12/31/2022
Q4
9/30/2022
Q3
6/30/2022
Q2
3/31/2022
Q1
ASSETS
Current Assets
Cash, cash equivalents, and short-term investments, including:282,700285,900293,100291,300306,200319,200
Cash and cash equivalents87,78674,66089,92182,959166,832171,892
Short-term investments194,887211,279203,168208,317139,388147,330
Other undisclosed cash, cash equivalents, and short-term investments27(39)1124(20)(22)
Receivables51,62559,31066,31270,42570,14265,320
Inventory, net of allowances, customer advances and progress billings18,84018,01819,23218,08618,86118,212
Inventory18,84018,01819,23218,08618,86118,212
Other undisclosed current assets7,6498,2009,2058,3468,6778,755
Total current assets:360,814371,428387,849388,157403,880411,487
Noncurrent Assets
Operating lease, right-of-use asset32,11833,43134,68935,84315,84117,122
Property, plant and equipment36,08435,50635,52934,04932,90427,564
Intangible assets, net (including goodwill)83,18485,25280,57481,37883,40285,132
Goodwill39,65539,61537,52337,52337,08436,983
Intangible assets, net (excluding goodwill)43,52945,63743,05143,85546,31848,149
Restricted cash and investments584520522198204214
Other noncurrent assets2,0362,0803,8284,8865,0575,192
Total noncurrent assets:154,006156,789155,142156,354137,408135,224
TOTAL ASSETS:514,820528,217542,991544,511541,288546,711
LIABILITIES AND EQUITY
Liabilities
Current Liabilities
Accounts payable and accrued liabilities41,42139,66442,14553,25061,15338,677
Employee-related liabilities14,31214,63111,418
Accounts payable9,88012,8619,94210,62516,89210,605
Accrued liabilities31,54126,80332,20328,31329,63016,654
Deferred revenue6,0585,8415,3424,9154,2953,941
Business combination, contingent consideration, liability9288251,0252,6502,7782,065
Other undisclosed current liabilities26,08925,49827,4639,47310,23022,237
Total current liabilities:74,49671,82875,97570,28878,45666,920
Noncurrent Liabilities
Long-term debt and lease obligation:    34,70816,06516,729
Liabilities, other than long-term debt30,88732,25433,655264277447
Deferred income tax liabilities51  1325194
Other liabilities247248249251252253
Operating lease, liability30,58932,00633,40634,70816,06516,729
Other undisclosed noncurrent liabilities4,2244,1142,4502,5722,9415,071
Total noncurrent liabilities:35,11136,36836,10537,54419,28322,247
Total liabilities:109,607108,196112,080107,83297,73989,167
Equity
Equity, attributable to parent405,213420,021430,911436,679443,549457,544
Common stock525252525252
Additional paid in capital923,514912,291898,806886,909875,213865,419
Accumulated other comprehensive loss(8,450)(7,439)(7,503)(8,809)(7,182)(5,090)
Accumulated deficit(509,903)(484,883)(460,444)(441,473)(424,534)(402,837)
Total equity:405,213420,021430,911436,679443,549457,544
TOTAL LIABILITIES AND EQUITY:514,820528,217542,991544,511541,288546,711

Income Statement (P&L) ($ in thousands)

9/30/2023
Q3
6/30/2023
Q2
3/31/2023
Q1
12/31/2022
Q4
9/30/2022
Q3
6/30/2022
Q2
3/31/2022
Q1
Revenues70,30177,26282,38479,35980,63479,416
Gross profit:70,30177,26282,38479,35980,63479,416
Operating expenses(97,925)(101,586)(101,504)(96,698)(102,353)(98,469)
Operating loss:(27,624)(24,324)(19,120)(17,339)(21,719)(19,053)
Nonoperating income (expense)2,603699964667(27)(607)
Other nonoperating income (expense)(271)(1,974)(924)(572)(553)(823)
Loss from continuing operations before income taxes:(25,021)(23,625)(18,156)(16,672)(21,746)(19,660)
Income tax expense (benefit)68(124)(173)(267)4912
Loss from continuing operations:(24,953)(23,749)(18,329)(16,939)(21,697)(19,648)
Loss before gain (loss) on sale of properties:(16,939)(21,697)(19,648)
Net loss available to common stockholders, diluted:(24,953)(23,749)(18,329)(16,939)(21,697)(19,648)

Comprehensive Income ($ in thousands)

9/30/2023
Q3
6/30/2023
Q2
3/31/2023
Q1
12/31/2022
Q4
9/30/2022
Q3
6/30/2022
Q2
3/31/2022
Q1
Net loss:(24,953)(23,749)(18,329)(16,939)(21,697)(19,648)
Comprehensive loss:(24,953)(23,749)(18,329)(16,939)(21,697)(19,648)
Other undisclosed comprehensive income (loss), net of tax, attributable to parent(1,011)641,306(1,627)(2,092)(420)
Comprehensive loss, net of tax, attributable to parent:(25,964)(23,685)(17,023)(18,566)(23,789)(20,068)

Statements Sources

The financial statements are based on the Company's filings with the U.S. Securities and Exchange Commission (SEC) through the Electronic Data Gathering, Analysis, and Retrieval system (EDGAR). The information is derived from the 10-K and 10-Q reports submitted to the SEC in XBRL (eXtensible Business Reporting Language) format and presented according to the US GAAP Taxonomy. Please review the original filings for a more detailed information.

Login to ReadyRatios

 

Have you forgotten your password?

Are you a new user?

Login As
You can log in if you are registered at one of these services: